EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC-ND 4.0

Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema

Kim Lien Huber, Heiko Stino, Irene Steiner, Philipp Fuchs, Felix Goldbach, Julia Mai, Bianca S Gerendas, Katharina Kriechbaum, Ursula Schmidt-Erfurth, Andreas Pollreisz

Investigative Ophthalmology & Visual Science · 2024-12-31 · 65 (14) · 46

DOI: 10.1167/iovs.65.14.46 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2024-12-31. Written by Kim Lien Huber and 9 co-authors. Institution: Medical University of Vienna, Department of Ophthalmology, Vienna, Austria. Major MEDLINE topics: Macular Edema, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Diabetic Retinopathy. Cited 27 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Povzetek ni na voljo.

Subjects

MeSH terms (MEDLINE)

Macular EdemaReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsDiabetic RetinopathyIntravitreal InjectionsVisual AcuityAngiogenesis InhibitorsTomography, Optical CoherenceHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeDrug SubstitutionVascular Endothelial Growth Factor AFollow-Up Studies

Substances

afliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Authors and institutions

  • Medical University of Vienna, Department of Ophthalmology, Vienna, Austria.
  • Medical University of Vienna, Center for Medical Data Science, Institute of Medical Statistics, Vienna, Austria.

Cite

APA

Huber, K. L., Stino, H., Steiner, I., Fuchs, P., Goldbach, F., Mai, J., Gerendas, B. S., Kriechbaum, K., Schmidt-Erfurth, U., & Pollreisz, A. (2024). Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science, 65(14), 46. https://doi.org/10.1167/iovs.65.14.46

Vancouver

Huber KL, Stino H, Steiner I, Fuchs P, Goldbach F, Mai J, et al. Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 2024;65(14):46. doi:10.1167/iovs.65.14.46

BibTeX
@article{Huber2024,
  author = {Huber, Kim Lien and Stino, Heiko and Steiner, Irene and Fuchs, Philipp and Goldbach, Felix and Mai, Julia and Gerendas, Bianca S and Kriechbaum, Katharina and Schmidt-Erfurth, Ursula and Pollreisz, Andreas},
  title = {Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {14},
  pages = {46},
  doi = {10.1167/iovs.65.14.46}
}
Start for free →